• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Blood transfusion after primary total knee arthroplasty can be significantly minimised through a multimodal blood-loss prevention approach.初次全膝关节置换术后输血可以通过多模式失血预防方法显著减少。
Int Orthop. 2014 Feb;38(2):347-54. doi: 10.1007/s00264-013-2188-7. Epub 2013 Dec 7.
2
Low-volume formulation of intra-articular tranexamic acid, 25-ml tranexamic acid (2.5 g) plus 20-ml saline, is effective in decreasing blood transfusion rate in primary total knee replacement even without preoperative haemoglobin optimization.关节腔内氨甲环酸的低容量配方,即25毫升氨甲环酸(2.5克)加20毫升生理盐水,即使在术前未优化血红蛋白的情况下,也能有效降低初次全膝关节置换术中的输血率。
Blood Coagul Fibrinolysis. 2016 Sep;27(6):660-6. doi: 10.1097/MBC.0000000000000457.
3
Can tranexamic acid and hydrogen peroxide reduce blood loss in cemented total knee arthroplasty?氨甲环酸和过氧化氢能否减少骨水泥型全膝关节置换术的失血量?
Arch Orthop Trauma Surg. 2014 Jul;134(7):997-1002. doi: 10.1007/s00402-014-1958-z. Epub 2014 Feb 13.
4
Topical Tranexamic Acid in Revision Total Knee Arthroplasty Reduces Transfusion Rates and May Be Associated With Earlier Recovery.局部使用氨甲环酸减少翻修全膝关节置换术的输血率并可能与更早的恢复相关。
J Arthroplasty. 2019 Jul;34(7S):S249-S255. doi: 10.1016/j.arth.2018.10.018. Epub 2018 Oct 25.
5
A comparative, retrospective study of peri-articular and intra-articular injection of tranexamic acid for the management of postoperative blood loss after total knee arthroplasty.一项关于关节周围和关节内注射氨甲环酸用于全膝关节置换术后失血管理的比较性回顾性研究。
BMC Musculoskelet Disord. 2016 Oct 19;17(1):438. doi: 10.1186/s12891-016-1293-3.
6
Intravenous versus topical tranexamic acid administration in primary total knee arthroplasty: a meta-analysis.全膝关节置换术中静脉注射与局部应用氨甲环酸的比较:一项荟萃分析
Knee Surg Sports Traumatol Arthrosc. 2017 Nov;25(11):3585-3595. doi: 10.1007/s00167-016-4235-6. Epub 2016 Jul 14.
7
Is there a need for routine post-operative hemoglobin level estimation in total knee arthroplasty with tranexamic acid use?在使用氨甲环酸的全膝关节置换术中,是否需要常规进行术后血红蛋白水平评估?
Knee. 2016 Mar;23(2):310-3. doi: 10.1016/j.knee.2015.08.016. Epub 2016 Jan 12.
8
Higher doses of topical tranexamic acid safely improves immediate functional outcomes and reduces transfusion requirement in total knee arthroplasty.高剂量局部氨甲环酸可安全改善全膝关节置换术后即刻功能结局,并减少输血需求。
Arch Orthop Trauma Surg. 2020 Dec;140(12):2071-2075. doi: 10.1007/s00402-020-03591-4. Epub 2020 Aug 29.
9
[Intra-Articular Application of Tranexamic Acid Significantly Reduces Blood Loss and Transfusion Requirement in Primary Total Knee Arthroplasty].氨甲环酸关节腔内应用显著减少初次全膝关节置换术中的失血量及输血需求
Acta Chir Orthop Traumatol Cech. 2016;83(4):254-262.
10
One Dose of Intravenous Tranexamic Acid Is Equivalent to Two Doses in Total Hip and Knee Arthroplasty.静脉注射氨甲环酸一剂的效果等同于全髋关节和膝关节置换术两剂的效果。
J Bone Joint Surg Am. 2018 Jul 5;100(13):1104-1109. doi: 10.2106/JBJS.17.00641.

引用本文的文献

1
Efficacy of Different Doses of Intra-Articular Tranexamic Acid for Reducing Blood Loss and Lower Limb Swelling After Total Knee Arthroplasty: A Prospective, Randomized, Controlled Trial.不同剂量关节腔内注射氨甲环酸对全膝关节置换术后减少失血及下肢肿胀的疗效:一项前瞻性、随机、对照试验
Orthop Surg. 2025 Mar;17(3):733-743. doi: 10.1111/os.14317. Epub 2024 Dec 13.
2
[Chinese expert consensus on clinical practice of daytime hip arthroplasty].《日间髋关节置换术临床实践中国专家共识》
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2024 May 15;38(5):513-520. doi: 10.7507/1002-1892.202403115.
3
Comparison of the effect of open-box versus closed-box prostheses on blood loss following total knee arthroplasty: a meta-analysis.全膝关节置换术后开放式与封闭式假体对失血影响的比较:一项荟萃分析
Ann Med Surg (Lond). 2024 Jan 3;86(2):1021-1028. doi: 10.1097/MS9.0000000000001657. eCollection 2024 Feb.
4
The incidence and risk factors for abnormal postoperative blood tests following primary total joint replacement.初次全关节置换术后血液检查异常的发生率及危险因素。
Bone Jt Open. 2023 Nov 24;4(11):899-905. doi: 10.1302/2633-1462.411.BJO-2023-0137.R1.
5
Effectiveness of Robotic Arm-Assisted Total Knee Arthroplasty on Transfusion Rate in Staged Bilateral Surgery.机器人手臂辅助全膝关节置换术在分期双侧手术中对输血率的有效性。
J Clin Med. 2023 Jul 9;12(14):4570. doi: 10.3390/jcm12144570.
6
Topical Tranexamic Acid Can Be Used Safely Even in High Risk Patients: Deep Vein Thrombosis Examination Using Routine Ultrasonography of 510 Patients.局部使用氨甲环酸即使在高危患者中也可安全使用:510 例患者的常规超声深静脉血栓检查。
Medicina (Kaunas). 2022 Nov 29;58(12):1750. doi: 10.3390/medicina58121750.
7
Efficacy of a Combined Intramedullary, Periarticular Injection, and Intraarticular Tranexamic Acid Application on Postoperative Bleeding in Total Knee Arthroplasty: A Retrospective Case-Matched Study.髓内、关节周围注射及关节腔内应用氨甲环酸联合治疗对全膝关节置换术后出血的疗效:一项回顾性病例对照研究。
Adv Orthop. 2022 Dec 10;2022:9175189. doi: 10.1155/2022/9175189. eCollection 2022.
8
The use of tranexamic acid reduces blood loss in osteotomy at knee level: a systematic review.氨甲环酸减少膝关节水平截骨术的失血:系统评价。
Knee Surg Sports Traumatol Arthrosc. 2022 Dec;30(12):4104-4114. doi: 10.1007/s00167-022-06938-z. Epub 2022 Mar 27.
9
Tranexamic Acid versus Epsilon-Aminocaproic Acid in Total Knee Arthroplasty: A Meta-Analysis.氨甲环酸与ε-氨基己酸在全膝关节置换术中的疗效比较:一项荟萃分析。
J Healthc Eng. 2021 Nov 3;2021:1758066. doi: 10.1155/2021/1758066. eCollection 2021.
10
Use of tranexamic acid in medial open wedge high tibial osteotomy.氨甲环酸在胫骨高位内侧开放楔形截骨术中的应用。
Arch Orthop Trauma Surg. 2022 Sep;142(9):2287-2293. doi: 10.1007/s00402-021-04219-x. Epub 2021 Oct 26.

本文引用的文献

1
Platelet-rich plasma prevents blood loss and pain and enhances early functional outcome after total knee arthroplasty: a prospective randomised controlled study.富血小板血浆预防全膝关节置换术后失血、疼痛并改善早期功能结局:一项前瞻性随机对照研究。
Int Orthop. 2014 Feb;38(2):387-95. doi: 10.1007/s00264-013-2136-6. Epub 2013 Oct 11.
2
Tranexamic acid and the reduction of blood loss in total knee and hip arthroplasty: a meta-analysis.氨甲环酸与全膝关节和髋关节置换术中失血的减少:一项荟萃分析。
BMC Res Notes. 2013 May 7;6:184. doi: 10.1186/1756-0500-6-184.
3
A meta-analysis of the effectiveness and safety of using tranexamic acid in primary unilateral total knee arthroplasty.一项关于在初次单侧全膝关节置换术中使用氨甲环酸的有效性和安全性的荟萃分析。
J Surg Res. 2013 Oct;184(2):880-7. doi: 10.1016/j.jss.2013.03.099. Epub 2013 Apr 25.
4
Clinical value of tranexamic acid in unilateral and simultaneous bilateral TKAs under a contemporary blood-saving protocol: a randomized controlled trial.在当代血液保护方案下氨甲环酸在单侧及同期双侧全膝关节置换术中的临床价值:一项随机对照试验
Knee Surg Sports Traumatol Arthrosc. 2014 Aug;22(8):1870-8. doi: 10.1007/s00167-013-2492-1. Epub 2013 Apr 17.
5
The effect of tranexamic acid on blood loss and transfusion rate in primary total knee arthroplasty.氨甲环酸对初次全膝关节置换术失血量和输血率的影响。
J Arthroplasty. 2013 Aug;28(7):1080-3. doi: 10.1016/j.arth.2012.11.016. Epub 2013 Mar 28.
6
Repeat-dose intravenous tranexamic acid further decreases blood loss in total knee arthroplasty.重复静脉注射氨甲环酸可进一步减少全膝关节置换术的失血。
Int Orthop. 2013 Mar;37(3):441-5. doi: 10.1007/s00264-013-1787-7. Epub 2013 Feb 1.
7
Minimising blood loss and transfusion in contemporary hip and knee arthroplasty.在当代髋膝关节置换术中减少失血和输血
J Bone Joint Surg Br. 2012 Nov;94(11 Suppl A):8-10. doi: 10.1302/0301-620X.94B11.30618.
8
Effectiveness and safety of tranexamic acid in reducing blood loss in total knee arthroplasty: a meta-analysis.氨甲环酸减少全膝关节置换术失血的有效性和安全性:一项荟萃分析。
J Bone Joint Surg Am. 2012 Jul 3;94(13):1153-9. doi: 10.2106/JBJS.K.00873.
9
Predicting need for allogeneic transfusion after total knee arthroplasty.预测全膝关节置换术后异体输血的需求。
J Arthroplasty. 2012 Jun;27(6):961-7. doi: 10.1016/j.arth.2011.10.008.
10
The effect of tranexamic acid on blood loss and use of blood products in total knee arthroplasty: a meta-analysis.氨甲环酸对全膝关节置换术失血和血制品使用的影响:一项荟萃分析。
Knee Surg Sports Traumatol Arthrosc. 2012 Sep;20(9):1742-52. doi: 10.1007/s00167-011-1754-z. Epub 2011 Nov 8.

初次全膝关节置换术后输血可以通过多模式失血预防方法显著减少。

Blood transfusion after primary total knee arthroplasty can be significantly minimised through a multimodal blood-loss prevention approach.

机构信息

Department of Orthopaedic Surgery, Hospital La Paz, Madrid, Spain.

出版信息

Int Orthop. 2014 Feb;38(2):347-54. doi: 10.1007/s00264-013-2188-7. Epub 2013 Dec 7.

DOI:10.1007/s00264-013-2188-7
PMID:24318318
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3923930/
Abstract

PURPOSE

Our aim was to clarify the effective decrease in blood transfusion after primary total knee arthroplasty (TKA) from a multimodal blood-loss prevention approach (MBLPA) and the related risk factors of blood transfusion.

METHODS

We retrospectively compared the rate of postoperative blood transfusion in 418 cases of primary TKA during 2010 from a single institution with two different groups of patients, allocating cases to the group with MBLPA (group 1, study group, N = 71) and controls to the group without MBLPA (group 2, standard group, N = 347). MBLPA procedure included pre-operative haemoglobin (Hb) optimisation; femoral canal obturation; limited incision and release; peri- and intra-articular use of saline with adrenalin, morpheic chloride, tobramycin, betamethasone and ropivacaine; tourniquet release after skin closure; 24 hour drain under atmospheric pressure; and two doses of tranexamic acid (TXA) i.v.. In the control group, surgeons followed the standard procedure without blood-saving techniques. Case-control comparison and blood transfusion risk factors were analysed.

RESULTS

Group 1 had a zero transfusion rate (0/71), whereas 27.4% of patients (95/347) in group 2 received allogenic blood transfusion. Significant transfusion risk factors were pre-operative Hb <12 g/dl), American Society of Anesthesiologists (ASA) status III and nonobese body mass index (BMI); Age and gender were not significant risk factors.

CONCLUSIONS

MBLPA in primary TKA was highly effective, with a zero transfusion rate. Risk factors for transfusion were determined, and eliminating them contributed to the avoidance of allogeneic blood transfusion in our study series.

摘要

目的

本研究旨在明确多模式失血预防(MBLPA)对初次全膝关节置换术(TKA)后输血的有效减少,并探讨输血的相关危险因素。

方法

我们回顾性比较了 2010 年单中心 418 例初次 TKA 的术后输血率,将患者分为 MBLPA 组(MBLPA 组,研究组,N=71)和对照组(无 MBLPA 组,标准组,N=347)。MBLPA 措施包括术前血红蛋白(Hb)优化、股骨髓腔填塞、小切口松解、关节内外应用含肾上腺素、盐酸吗啡、妥布霉素、倍他米松和罗哌卡因的生理盐水、皮肤缝合后止血带松解、24 小时大气压引流和 2 次静脉滴注氨甲环酸(TXA)。对照组的外科医生遵循没有节约血液技术的标准手术程序。对病例对照进行比较并分析输血的危险因素。

结果

MBLPA 组 71 例患者中无一例输血(0/71),而对照组 347 例患者中 27.4%(95/347)需要异体输血。输血的显著危险因素是术前 Hb <12 g/dl、美国麻醉师协会(ASA)分级 III 和非肥胖体质指数(BMI);年龄和性别不是危险因素。

结论

初次 TKA 中采用 MBLPA 可有效降低输血率,确定了输血的危险因素,通过消除这些危险因素,可避免本研究系列中异体输血。